BioNexus Gene Lab Corp (BGLC) Q2 2024 Earnings
BGLC·Reported August 14, 2024·Before market open
BioNexus Gene Lab Corp reported Q2 2024 revenue of $2.0M (-23.1% YoY). Diluted EPS came in at $0.10.
Revenue
$2.0M
Diluted EPS
$0.10
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about BioNexus Gene Lab Corp's Q2 2024 earnings report.
BioNexus Gene Lab Corp (BGLC) reported Q2 2024 earnings on August 14, 2024 before market open.
BioNexus Gene Lab Corp reported revenue of $2.0M and diluted EPS of $0.10 for Q2 2024.
Compared to the same quarter a year prior, revenue declined 23.1% from $2.6M a year earlier.
You can read the 10-Q periodic report (0001477932-24-004792) directly on SEC EDGAR. The filing index links above go to sec.gov.